Prescription drug · BLA
Novolog (Insulin aspart) NDC 0169-6338
Insulin aspart 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · Novo Nordisk
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Novolog
- Generic name (nonproprietary)
- insulin aspart
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Novo NordiskNDC labeler code 0169
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020986
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 0169-6338_de82c22d-ea25-44ef-8bcd-c3cda9e84e59SPL ID de82c22d-ea25-44ef-8bcd-c3cda9e84e59SPL set ID 3a1e73a2-3009-40d0-876c-b4cb2be56fc5RxCUI 311040, 351926, 1653196, 1653198, 1653202, 1653204UNII D933668QVX, 059QF0KO0R
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 0169-6338
- What is NDC 0169-6338?
- 0169-6338 is the product NDC for Novolog (insulin aspart), Insulin aspart 100 [iU]/mL injection, solution, listed with the FDA by Novo Nordisk.
- What drug is associated with this NDC?
- Novolog (Insulin aspart).
- What is the active ingredient?
- Insulin aspart.
- Who is the labeler?
- Novo Nordisk, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Novolog?
- 8 other product NDCs are listed under this name. See all Novolog NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Novolog products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2101 | 00169-2101-25 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6339 | 00169-6339-1000169-6339-98 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1678 | 50090-1678-00 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4500 | 50090-4500-00 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2100 | 00169-2100-11 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-3303 | 00169-3303-1200169-3303-9000169-3303-91 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-7501 | 00169-7501-1100169-7501-90 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1664 | 50090-1664-00 |
Other NDCs under BLA 020986
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4955 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4956 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | REMEDYREPACK INC. | 70518-3865 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-100 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-102 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-103 |
| Insulin Diluting Medium for NovoLogwater injection | Water 1 mL/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2001 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2100 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2101 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-3303 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6339 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-7501 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1664 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1678 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4500 |